|
|
|
Company
Name |
Short
Summary |
| Advanced
Magnetics |
Advanced
Magnetics, Inc. designs, develops and manufactures
contrast agents for Magnetic Resonance Imaging
(MRI). |
| Alkermes |
Alkermes
is focused on drug delivery. There are several
partnered programs as well as in-house development
activites. |
| Alnylam Pharmaceuticals |
Alnylam Pharmaceuticals is focused on the research and development of RNAi therapeutics for infectious diseases and cancer. |
| Altus
Biologics |
Altus
is involved in the discovery, development and
manufacture of highly purified and stabilized
protein-based products. |
| Amgen |
Amgen
develops therapeutic proteins in oncology/hematopoiesis,
inflammation, and neurobiology/endocrinology. |
| Anchor Therapeutics |
Anchor Therapeutics is focused on development of pepducins for targeting G protein coupled receptors (GPCRs) on the inside surface of the cell membrane. |
| Archemix |
Archemix is focused the research and development of synthetic oligonucleotide aptamers for the treatment of acute and chronic diseases. |
| Ariad
Pharmaceuticals |
Ariad
is a leader in the design and development of a
new class of pharmaceuticals that target intracellular
signaling pathways to alter the course of disease. |
| AVEO Pharmaceuticals |
AVEO Pharmaceuticals is focused on discovering, developing and commercializing novel cancer therapeutics. |
| Bayer |
Bayer develops and markets various
drugs. Oncogene Science, a part of Bayer Healthcare is based in Cambridge. |
| Biogen Idec |
Biogen Idec is focused on research, development, and commercialization of products in neurology, oncology and immunology. |
| Biopure
|
Biopure
Corporation develops, manufactures and markets
oxygen therapeutics. |
| Celexion |
Celexion is focused on using its proprietary SECANT™ platform to discover and engineer new proteins for applications in therapeutics, diagnostics, and life science tools. |
| Cerulean Pharma |
Cerulean Pharma is discovering and developing nanopharmaceuticals (drugs within ultra-small particles) to preferentially directing drug-containing nanoparticles to diseased tissues, resulting in sustained release of the drug in target cells and minimizing systemic exposure. |
| CombinatoRx |
CombinatoRx,
Incorporated is a biopharmaceutical company focused
on developing new medicines built from synergistic
combinations of approved drugs. |
| Critical Biologics |
Critical Biologics is focused on the development and commercialization of diagnostics and therapeutics that predict and regulate inflammatory responses to life-threatening diseases. |
| Curis |
Curis is a focused on its signaling pathway drug technologies to identify targeted small molecule drug candidates for cancer. |
| Dyax |
Dyax
is involved in the discovery, development, and commmercialization
of fully human monoclonal antibodies as well as
small proteins and peptides. |
| EMD Chemicals |
EMD Chemicals is focused on providing industrial and laboratory chemicals for the pharmaceutical and biotechnology industry. |
| FoldRx Pharmaceuticals |
FoldRx Pharmaceuticals is focused on small molecule therapeutics to treat diseases of protein misfolding. |
| Genocea Biosciences |
Genocea Biosciences is focused on the research and development of vaccines that induce T cell immunity. |
| Genzyme |
Genzyme
is a highly diversified family of companies committed
to redefining patient care worldwide through the
introduction of innovative products and services
for major unmet medical needs. |
| Helicos BioSciences |
Helicos BioSciences is focused the development and commerciailzation of genetic analysis technologies for the research and diagnostic markets. |
| Hydra Biosciences |
Hydra Biosciences is focused on development of drugs targeting ion channels to treat pain, inflammation, cardiovascular and other diseases. |
| Idenix Pharmaceuticals |
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases. |
| Idera Pharmaceuticals |
Idera Pharmaceuticals is focused on the development of TLR agonists as drug candidates to treat infectious diseases, autoimmune and inflammatory diseases, cancer, and respiratory diseases, and for use as vaccine adjuvants. |
| Immunogen |
Immunogen
is involved in the discovery, development, and commercialization
of therapeutic monoclonal antibodies and treatments
in oncology. |
| Infinity Pharmaceuticals |
Infinity Pharmaceuticals is focused on the discovery, development, and commercialization of drugs for the treatment of cancer and related conditions. |
| Javelin Pharmaceuticals |
Javelin Pharmaceuticals is focused on the development of drugs to treat intense, moderate-to-severe pain. |
| Merrimack Pharmaceuticals |
Merrimack Pharmaceuticals is focused on the development of medicines for the treatment of autoimmune disease and cancer. |
| Mersana Therapeutics |
Mersana Therapeutics is focused on application of its biodegradable polymer platform (Fleximer®) to drug and biologics development. |
| Millennium
Pharmaceuticals |
Millennium
Pharmaceuticals, Inc. is a leading drug discovery
and development company, incorporating large-scale
genetics, genomics, high throughput screening
and informatics in an integrated science and technology
platform. |
| Molecular Insight Pharmaceuticals |
Molecular Insight Pharmaceuticals is focused on the research and development of targeted radiotherapeutics and imaging agents for treatment of patients with cancer. |
| Momenta Pharmaceuticals |
Momenta Pharmaceuticals is focused on the research, development, and commercialization of products that are complex mixture generic and novel drugs. |
| PerkinElmer |
PerkinElmer is focused on the development and commercialization of instruments, reagents, software and services for human and environmental health applications. |
| Peptimmune |
Peptimmune is focused on the develompent of peptide and peptide-copolymer therapeutics for the treatment of CNS and Autoimmune disorders. |
| Pfizer |
Pfizer Inc. is involved in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. |
| PPD |
PPD is focused on drug discovery, development and lifecycle management services to companies in the pharmaceutical, biotechnology, medical device industries. |
| Quanterix |
Quanterix is focused on utilizing its proprietary Single Molecule Array (SiMoA™) technology for the development and commercialization of diagnostic tests utilizing human blood. |
| Quintiles |
Quintiles is a contract research organization focused on providing integrated bio and pharmaceutical services. Quintiles also offers commercial, consulting and capital services. |
| Sanofi-Aventis |
Sanofi-Aventis is a large pharmaceutical company focused on the discovery, development, and commercialization of a wide range of drugs. A research and development facility is located in Cambridge. |
| Seaside Therapeutics |
Seaside Therapeutics is focused on the development of small molecule drugs to treat Fragile X Syndrome, autism and other disorders of brain development. |
| Sirtris Pharmaceuticals |
Sirtris Pharmaceuticals is focused on the disocovery and development of orally available, small molecule drugs to treat diseases associated with aging, such as Type 2 Diabetes. |
| Taligen Therapeutics |
Taligen Therapeutics is focused on targeted therapies that regulate the complement system to treat inflammatory and immune diseases. |
| Tolerx |
Tolerx is focused on the research and development of products which normalize the immune system to treat autoimmune diseases, diabetes, and cancer. |
| TransMolecular |
TransMolecular is focused on development of novel proprietary drugs to diagnose and treat human cancers using a novel tumor targeting platform called TM601 (a 36-amino acid peptide isolated from scorpion venom). |
| Variation Biotechnologies |
Variation Biotechnologies is focused on the research and development of vaccines. |
| Vertex
Pharmaceuticals |
The
Company has 12 drug candidates in development to
treat viral diseases, inflammation, cancer, autoimmune
diseases and neurological disorders. |
| Virdante Pharmaceuticals |
Virdante Pharmaceuticals is focused on the develompent of drugs for autoimmune and inflammatory diseases. |
| Zalicus |
Zalicus is focused on the research, development, and commercialization of treatments for pain and inflammatory diseases. |
